Metraipolis › archive › dc_86c8490221a8

Validation of Chinese medicine syndrome differentiation in early breast cancer: a multicenter prospective clinical study — Europe PMC PMID:41704617

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41704617
DOI
10.3389/fonc.2026.1652339
License (as archived)
solo-consultazione
Archived
2026-11-06T08:01:00.341Z
SHA-256 of the archived text
980d17031f56c5fff3ceb760bea9ab6aa7514903a3a2b688dab79f9c4f0540be
Stable URL of this page
https://metraipolis.com/documento/dc_86c8490221a8

How to cite

Validation of Chinese medicine syndrome differentiation in early breast cancer: a multicenter prospective clinical study — Europe PMC PMID:41704617 — Europe PMC (en), https://europepmc.org/article/MED/41704617 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_86c8490221a8 (Metraipolis archive dc_86c8490221a8, sha256 980d17031f56c5fff3ceb760bea9ab6aa7514903a3a2b688dab79f9c4f0540be)
BibTeX
@misc{dc86c8490221a8,
  title = {Validation of Chinese medicine syndrome differentiation in early breast cancer: a multicenter prospective clinical study — Europe PMC PMID:41704617},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41704617},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_86c8490221a8; sha256 980d17031f56c5fff3ceb760bea9ab6aa7514903a3a2b688dab79f9c4f0540be},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41704617. Agents can read the archived copy with the MCP tool read_document.